The Society for Medicines Research will be hosting The Best of Both Worlds : Innovation, Collaboration and Synergy between CROs and their Client Partners to address the increasing scientific complexity, rising R&D costs and more challenging market dynamics, facing the pharmaceutical industry. It will discuss novel ways to increase productivity and success rates in the pursuit of new therapies for human disease. Continuing a theme focused on new forms of innovation and collaboration in drug discovery and development, this meeting will focus on how biotech and pharma companies are engaging ever more closely with their partner Contract Research Organisations, in the design and development of new and transformational therapeutics.
This meeting will showcase innovation in science that has emerged from several successful Client-CRO partnerships which have moved beyond fee-for-service agreements, towards much broader risk-sharing and complementary collaborations.
Principle Research Leader, Dr Gary Newton (Domainex) will co-present with Dr David Moffat (Macrophage Pharma):
“ The advantages of selective drug delivery to tumour myeloid cells using Esterase Sensitive Motif TM technology”
If you would like to find out more, or wish to meet with Gary at the event, please get in touch.